Nagasaki University and NEC OncoImmunity Collaborate to Desi

TOKYO, Aug 21, 2023 - (JCN Newswire) - Nagasaki University and NEC OncoImmunity (NOI), a leading artificial intelligence (AI) company, have announced that they will collaborate to use NOI's AI platform to design universal vaccines against highly pathogenic and tropical infectious diseases.The collaboration between NOI and Nagasaki University aims to harness the power of advanced AI to optimize vaccine designs...

Related Keywords

Nagasaki , Yamagata , Japan , Tokyo , Dejima , Takeshi Nagayasu , Trevor Clancy , Masamitsu Kitase , Richard Stratford , Vaccine Development Program , Nec Ai Drug Development Business , Development For Preparedness , Life Science Division , Biomedical Advanced Vaccine Research , Trustee Strategic Development , Asia Research Institute Of Endemics , Nagasaki Medical College , Nagasaki University , Rd Center , Vaccine Informatics Department , Strategic Center , Institute Of Tropical Medicine , Infectious Disease Research Alliance , Tropical Medicine , Chief Scientific Officer , Strategic Development , Corporate Senior , East Asia Research Institute , Medical College , Disease Research Alliance , Leading Rd Center , Development Business ,